2024.07.29

CPDC Celebrates Founder John Valliant and His Sixteen-Year Commitment to CPDC

2024.03.19

CPDC Marks Sixteen Years of Innovation and Success

2024.03.13

CPDC Announces Closure of Phase 3 Clinical Trial of [18F]PSMA-1007 Prostate Cancer Diagnostic Imaging Agent

2023.07.06

CPDC Funds Pediatric Brain Cancer Imaging Research at Centre for Addiction and Mental Health

2023.07.04

CPDC & adMare Fund Research at Simon Fraser University for Cancer Imaging

2023.06.27

CPDC Announced as Co-lead on $35MM SIF Grant

2022.11.01

PET/CT scans assist in decreasing cancer mortality over last 20 years

2022.08.03

Important advancements in the treatment of prostate cancer

2022.11.01

Using an FDA-approved prostate cancer PET agent for brain imaging